Gut microbiota and gut-derived metabolites in defining multiple sclerosis phenotypic continuum.
Saved in:
| Title: | Gut microbiota and gut-derived metabolites in defining multiple sclerosis phenotypic continuum. |
|---|---|
| Authors: | Montini F; Department of Neurology, Mayo Clinic, Rochester, MN, United States.; Mayo Clinic Center for Multiple Sclerosis and Autoimmune Neurology, Rochester, MN, United States., Mangalam A; Department of Pathology, Carver College of Medicine, University of Iowa, Iowa City, IA, United States.; Iowa City Veterans Affairs Health Care System, Iowa City, IA, United States., Zeydan B; Department of Neurology, Mayo Clinic, Rochester, MN, United States.; Mayo Clinic Center for Multiple Sclerosis and Autoimmune Neurology, Rochester, MN, United States., Murray J; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States., Kantarci OH; Department of Neurology, Mayo Clinic, Rochester, MN, United States.; Mayo Clinic Center for Multiple Sclerosis and Autoimmune Neurology, Rochester, MN, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Jul 01; Vol. 17, pp. 1858047. Date of Electronic Publication: 2026 Jul 01 (Print Publication: 2026). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1858047 |
